This is a revised renewal application of grant T32 AR050958 to continue support for basic, translational and clinical Research Training in Inflammatory and Fibrosing Diseases centered in the Rheumatology Division at the Medical University of South Carolina (MUSC). The ultimate goal is to improve the healthcare and outcomes for individuals with rheumatic diseases in the southeastern United States, emphasizing research relevant to the disproportionate burden of disease borne by African Americans. Our training program emphasizes the interrelationship between inflammation and fibrosis and the impact of these biologic processes on end organ function such as renal disease in lupus and lung disease in scleroderma. The participating faculty members have particular strengths and existing collaborations in the areas of health outcomes and community-based research, epidemiology of rheumatic diseases, health disparities, gene/environment interactions, innate immunity and adoptive immunotherapy, lupus nephritis, signaling pathways leading to fibrosis, matrix proteins, scleroderma lung disease and disease biomarkers. Trainees may matriculate to one of three research tracks: the Bench Research Track for Clinicians, the Clinical Investigator Track including a Master of Science in Clinical Research degree, and the The ranslational Research Track for Non-Clinicians. The training program is structured to help trainees achieve critical skills for sustained careers in academic medicine in a flexible framework that accommodates a diverse range of prior education and experience and multiple modes of investigation focused on the shared programmatic theme. This training program is currently completing its 10th year. To date, the grant has supported a total of 13 postdoctoral fellows, 11 females and 2 males, including 3 underrepresented minority (URM) fellows. Of the cadre of 13, 8 are or soon will be in academic positions, 1 in government research, 1 in the nonprofit sector, 1 in industry research and 2 in clinical practice. In the current funding cycle, he grant has supported 9 fellows: 3 MDs, 1 MD/PhD and 5 PhDs. The trainees in the current cycle have been productive with 27 manuscripts published or in press during the time period of this award with 15 in the past 12 months. More than 30 abstracts were presented by training grant fellows as a result of this grant. The present application is a request for continuation of 3 fellowship slots. Fellows will be on the research training grant for two years with an option for a third year if justified based on productivity and potential for making additional significant progress toward attaining faculty status and/or competitive funding grant funding as PI. The Internal Advisory Committee will review and approve the selection and annual re-appointment based on specific criteria. Evaluation data and slot availability. We have filled all the slots at ll times from a pool of highly qualified applicants.

Public Health Relevance

This program will provide research training for individuals who will make important contributions to our understanding of how inflammation and fibrosis contribute to rheumatic diseases such as scleroderma and systemic lupus erythematosus. This program has a special focus on investigating the underlying reasons why African Americans have more complications with scleroderma or lupus and more rapid disease progression than Caucasians.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32AR050958-13
Application #
9539725
Study Section
Special Emphasis Panel (ZAR1)
Program Officer
Park, Heiyoung
Project Start
2004-08-01
Project End
2021-07-31
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
13
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29403
Elvington, M; Schepp-Berglind, J; Tomlinson, S (2015) Regulation of the alternative pathway of complement modulates injury and immunity in a chronic model of dextran sulphate sodium-induced colitis. Clin Exp Immunol 179:500-8
Reese, Charles; Perry, Beth; Heywood, Jonathan et al. (2014) Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease. Arthritis Rheumatol 66:1909-19
Lee, Rebecca; Reese, Charles; Bonner, Michael et al. (2014) Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease. Am J Physiol Lung Cell Mol Physiol 306:L736-48
Parks, John L; Taylor, Marian H; Parks, Laura P et al. (2014) Systemic sclerosis and the heart. Rheum Dis Clin North Am 40:87-102
Li, Qingdi Quentin; Lee, Rebecca X; Liang, Huasheng et al. (2013) Anticancer activity of ?-Elemene and its synthetic analogs in human malignant brain tumor cells. Anticancer Res 33:65-76
Bedoya, Simone K; Wilson, Tenisha D; Collins, Erin L et al. (2013) Isolation and th17 differentiation of naïve CD4 T lymphocytes. J Vis Exp :e50765
Ghatnekar, Angela; Chrobak, Izabela; Reese, Charlie et al. (2013) Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension. Am J Pathol 182:2391-406
Li, Qingdi Quentin; Lee, Rebecca X; Liang, Huasheng et al. (2013) Enhancement of cisplatin-induced apoptosis by ?-elemene in resistant human ovarian cancer cells. Med Oncol 30:424
Baker, DeAnna A; Eudaly, Jackie; Smith, Charles D et al. (2013) Impact of sphingosine kinase 2 deficiency on the development of TNF-alpha-induced inflammatory arthritis. Rheumatol Int 33:2677-81
Arsenault, Patrick R; Pei, Fei; Lee, Rebecca et al. (2013) A knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism. J Biol Chem 288:33571-84

Showing the most recent 10 out of 16 publications